Compass

Compass Pathways is focused on researching and developing innovative therapies for people suffering from mental illnesses, particularly treatment resistant depression. The company is best known for its work on developing psilocybin therapy, which involves psychoactive substances in magic mushrooms to treat mental health disorders. The company has received breakthrough therapy designation from the FDA for this treatment. Breakthrough therapy designation is intended to expedite the development and review of drugs for serious or life threatening conditions.